Cost Effectiveness of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: Results of the ROSETTA Randomized Trial

Heidi S. Harvie,Cindy L. Amundsen,Simon Neuwahl,Amanda Honeycutt,Emily S. Lukacz,Vivian W. Sung,Rebecca G. Rogers,David R. Ellington,Cecile A. Ferrando,Christopher Chermansky,Donna Mazloomdoost,Sonia Thomas

Cost Effectiveness of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: Results of the ROSETTA Randomized Trial

2019

Heidi S. Harvie
Cindy L. Amundsen
Simon Neuwahl
Amanda Honeycutt
Emily S. Lukacz
Vivian W. Sung
Rebecca G. Rogers
David R. Ellington
Cecile A. Ferrando
Christopher Chermansky
Donna Mazloomdoost
Sonia Thomas

Purpose:Sacral neuromodulation and intradetrusor injection of onabotulinumtoxinA are therapies for refractory urgency-urinary incontinence. Sacral neuromodulation involves surgical implant of a dev...

Keywords:

Randomized controlled trial
Medicine
Neuromodulation
Urinary incontinence
Refractory
Urology
Transcutaneous electric nerve stimulation
cost effectiveness
sacral nerve stimulation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations